The incidence of anal cancer and mortality due to anal cancer have increased in recent years. Most anal cancers are caused by infection with human papillomavirus (HPV). While HPV infections are often transient, persistent infections with oncogenic or cancer-causing types can lead to dysplasia, which can in turn progress to squamous cell carcinoma. The goal of screening for anal dysplasia is to detect and treat anal cancer precursors before they develop into cancer. Anal cancer can also be prevented through HPV vaccination.
Learning Resources — Cancer and LGBTQIA+ People
An Introduction to Anal Cancer and Anal Dysplasia Screening
Presented by Dr. Ami Multani, this webinar will present the current evidence base on screening (living with and without HIV) for anal cancer, and will discuss the potential benefits and drawbacks of screening patients in primary care. Resources will be provided on further training for performing anal Pap and high-resolution anoscopy.
- Filed under
- Cancer and LGBTQIA+ People
Culturally Responsive Cervical and Breast Cancer Screenings for LGBTQIA+ Communities
This webinar will discuss performing cervical and breast cancer screening exams in a way that is affirming for LGBTQIA+ patients. We will review patient communication, preparation and completion of the exams, and gender affirming clinical documentation. This session will support health centers in population needs assessment and management, community needs and resource mapping, and clinical effectiveness of care within the population health and social determinants of health domain.
- Filed under
- Cancer and LGBTQIA+ People
